RVMD icon

Revolution Medicines
RVMD

Overview Fund Activity

252 hedge funds and large institutions have $7.66B invested in Revolution Medicines in 2024 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 92 increasing their positions, 62 reducing their positions, and 22 closing their positions.

Holders
252
Holders Change
+30
Holders Change %
+13.51%
% of All Funds
3.65%
Holding in Top 10
18
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.26%
New
54
Increased
92
Reduced
62
Closed
22
Calls
$13.2M
Puts
$36.9M
Net Calls
-$23.7M
Net Calls Change
-$26.4M

Top Buyers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$83.1M
2
FCM
2
Farallon Capital Management
California
$513M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$278M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$188M
5
Goldman Sachs
5
Goldman Sachs
New York
$107M

Top Sellers

1
BI
1
BVF Inc
California
$158M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$517M
3
Norges Bank
3
Norges Bank
Norway
$0
4
AI
4
Alphabet Inc
California
$193M
5
AG
5
Artal Group
Luxembourg
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$676M 14,911,373 +533,076 +4%
BlackRock
2
BlackRock
New York
$629M 13,866,858 +458,145 +3%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$517M 11,401,394 -2,258,802 -17%
FCM
4
Farallon Capital Management
California
$513M 11,317,692 +1,560,000 +16%
BBA
5
Baker Bros. Advisors
New York
$343M 7,569,090 – –
NI
6
Nextech Invest
Switzerland
$286M 6,296,740 – –
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$278M 6,137,244 +1,497,026 +32%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$266M 5,875,893 +250,037 +4%
PBA
9
Paradigm Biocapital Advisors
New York
$241M 5,314,089 +55,000 +1%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$241M 5,313,305 +96,646 +2%
State Street
11
State Street
Massachusetts
$239M 5,279,584 +208,516 +4%
BG
12
Bellevue Group
Switzerland
$221M 4,871,360 -157,740 -3%
BC
13
Boxer Capital
California
$194M 4,279,464 – –
AI
14
Alphabet Inc
California
$193M 4,256,175 -1,050,900 -20%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$188M 4,137,920 +1,022,345 +33%
CC
16
Casdin Capital
New York
$187M 4,114,283 -292,592 -7%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$165M 3,627,025 +291,369 +9%
BI
18
BVF Inc
California
$158M 3,478,612 -2,502,600 -42%
WP
19
Woodline Partners
California
$156M 3,433,713 +142,922 +4%
DM
20
Deerfield Management
New York
$132M 2,912,692 -177,381 -6%
ACM
21
AH Capital Management
California
$125M 2,748,523 – –
Goldman Sachs
22
Goldman Sachs
New York
$107M 2,354,602 +906,507 +63%
Holocene Advisors
23
Holocene Advisors
New York
$97.5M 2,149,561 -53,913 -2%
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
$83.1M 1,832,021 +1,832,021 New
Charles Schwab
25
Charles Schwab
California
$80M 1,763,117 +653,433 +59%
1
2 3 4 5